Healthcare provider profile · identity verified

Susan L. Sette, MD

Family Practice · BALDWIN PARK, CA · NPI 1639221005

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	468	177
Lisinopril	Lisinopril	224	94
Amlodipine Besylate	Amlodipine Besylate	179	74
Losartan Potassium	Losartan Potassium	176	72
Atenolol	Atenolol	166	68
Levothyroxine Sodium	Levothyroxine Sodium	164	61
Rosuvastatin Calcium	Rosuvastatin Calcium	163	65
Simvastatin	Simvastatin	150	60
Albuterol Sulfate Hfa	Albuterol Sulfate	121	59
Metformin Hcl	Metformin Hcl	114	47
Famotidine	Famotidine	112	51
Gabapentin	Gabapentin	107	32
Omeprazole	Omeprazole	99	51
Trazodone Hcl	Trazodone Hcl	91	37
Alendronate Sodium	Alendronate Sodium	86	36
Metoprolol Tartrate	Metoprolol Tartrate	86	34
Hydrochlorothiazide	Hydrochlorothiazide	84	34
Pravastatin Sodium	Pravastatin Sodium	83	33
Furosemide	Furosemide	79	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	37
Meloxicam	Meloxicam	64	30
Ibuprofen	Ibuprofen	60	29
Glipizide	Glipizide	57	25
Sertraline Hcl	Sertraline Hcl	51	23
Potassium Chloride	Potassium Chloride	50	24
Triamcinolone Acetonide	Triamcinolone Acetonide	44	26
Ezetimibe	Ezetimibe	43	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	16
Tramadol Hcl	Tramadol Hcl	41	16
Acyclovir	Acyclovir	39	20
Prednisone	Prednisone	39	37
Spiriva Respimat	Tiotropium Bromide	39	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	38	14
Metformin Hcl Er	Metformin Hcl	37	22
Clopidogrel	Clopidogrel Bisulfate	36	15
Humulin N	Insulin Nph Human Isophane	36	11
Alvesco	Ciclesonide	34	12
Wixela Inhub	Fluticasone Propion/Salmeterol	34	14
Morphine Sulfate Er	Morphine Sulfate	33	suppressed
Spironolactone	Spironolactone	32	12
Jardiance	Empagliflozin	31	14
Cephalexin	Cephalexin	29	24
Pantoprazole Sodium	Pantoprazole Sodium	29	15
Clonidine Hcl	Clonidine Hcl	24	suppressed
Naproxen	Naproxen	24	14
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	12
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Carvedilol	Carvedilol	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	15
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Lovastatin	Lovastatin	16	suppressed
Ondansetron Odt	Ondansetron	16	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Humulin R	Insulin Regular, Human	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	12	12
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Estradiol	Estradiol	12	suppressed
Hydrocortisone	Hydrocortisone	12	11
Tamsulosin Hcl	Tamsulosin Hcl	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error